Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF 03716556

Copy Product Info
🥰Excellent
TargetMol
Catalog No. T2093Cas No. 928774-43-0
Alias PF-3716556

PF 03716556 (PF-3716556) , an effective and specific P-CAB (potassium-competitive acid blocker), is utilized for the treatment of gastroesophageal reflux disease.

PF 03716556

PF 03716556

Copy Product Info
🥰Excellent
TargetMol
Purity: 99.95%
Catalog No. T2093Alias PF-3716556Cas No. 928774-43-0
PF 03716556 (PF-3716556) , an effective and specific P-CAB (potassium-competitive acid blocker), is utilized for the treatment of gastroesophageal reflux disease.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35In StockIn Stock
5 mg$55In StockIn Stock
10 mg$88In StockIn Stock
25 mg$177In StockIn Stock
50 mg$337In StockIn Stock
100 mg$532In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.95%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PF 03716556 AI Summary
PF 03716556 exhibits bioactivity as an inhibitor of the proliferation of various strains of Plasmodium falciparum, with potencies ranging from 133.2 nM to 23694.5 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PF 03716556 (PF-3716556) , an effective and specific P-CAB (potassium-competitive acid blocker), is utilized for the treatment of gastroesophageal reflux disease.
Targets&IC50
H+, K+-ATPase:6.5(pIC50)
In vitro
PF 03716556 is highly selective for H+ (pIC50=6.026),K+-ATPase (pIC50=7.095).
In vivo
PF 03716556 is highly selective for H+ (pIC50=6.026),K+-ATPase (pIC50=7.095).
SynonymsPF-3716556
Chemical Properties
Molecular Weight394.47
FormulaC22H26N4O3
Cas No.928774-43-0
SmilesCN(CCO)C(=O)c1cc(N[C@@H]2CCOc3cccc(C)c23)c2nc(C)cn2c1
Relative Density.1.30 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 39.5 mg/mL (100.13 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5350 mL12.6752 mL25.3505 mL126.7524 mL
5 mM0.5070 mL2.5350 mL5.0701 mL25.3505 mL
10 mM0.2535 mL1.2675 mL2.5350 mL12.6752 mL
20 mM0.1268 mL0.6338 mL1.2675 mL6.3376 mL
50 mM0.0507 mL0.2535 mL0.5070 mL2.5350 mL
100 mM0.0254 mL0.1268 mL0.2535 mL1.2675 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF 03716556 | purchase PF 03716556 | PF 03716556 cost | order PF 03716556 | PF 03716556 chemical structure | PF 03716556 in vivo | PF 03716556 in vitro | PF 03716556 formula | PF 03716556 molecular weight